UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial

Autor: Haakensen, Vilde Drageset, Öjlert, Åsa Kristina, Thunold, Solfrid, Farooqi, Saima, Nowak, Anna K., Chin, Wee L., Grundberg, Oscar, Szejniuk, Weronika Maria, Cedres, Susana, Sørensen, Jens Benn, Dalen, Tonje Sofie, Lund-Iversen, Marius, Bjaanæs, Maria, Helland, Åslaug
Zdroj: In European Journal of Cancer May 2024 202
Databáze: ScienceDirect
Externí odkaz: